Strategies to Improve the Oxidative Stability and Shelf Life of Sacha Inchi oil in Pharmaceutical Applications Nur Aisyah, Feggy Yustika Sitinjak, Sriwidodo, Patihul Husni Applied Food Research, 2026 Sacha Inchi (Plukenetia volubilis L.) oil, abundant in polyunsaturated fatty acids (PUFAs), presents significant nutritional and therapeutic promise for traditional formulations; yet, it is highly susceptible to oxidation, compromising its stability and reducing shelf life. Diverse modification approaches, including encapsulation, co-microencapsulation (especially with natural antioxidants), and nanoemulsions, have demonstrated substantial improvements in oxidative stability and shelf life relative to conventional systems. Techniques for preparation, including spray drying, freeze-drying, ultrasonic emulsification, and high-pressure homogenization, along with optimization through Response Surface Methodology (RSM), provide stringent control of essential parameters to improve quality, safety, and performance. This study consolidates recent advancements in techniques for Sacha Inchi oil and delineates future potential for safer and more effective solutions.
Chitosan-based microparticulate systems to enhance the bioavailability of natural products: Mechanistic insights and pharmaceutical applications Patonah Hasimun, Cecep Suhandi, Elis Susilawati, Dolih Gozali, Rahmat Santoso, Taofik Rusdiana, Diki Prayugo Wibowo, Sriwidodo Sriwidodo Carbohydrate Polymer Technologies and Applications, 2026 Chitosan-based microencapsulation systems are emerging as promising, biocompatible carriers designed to overcome major pharmacokinetic limitations of natural therapeutic agents. Many phytochemicals exhibit poor water solubility, rapid degradation, and low intestinal absorption. As a biodegradable and mucoadhesive biopolymer, chitosan offers distinct advantages by controlling drug release, protecting compounds from enzymatic breakdown, and enhancing passive absorption through the paracellular pathway. These properties make chitosan suitable for delivering diverse bioactive molecules, including alkaloids, phenolics, and botanical extracts. This review examines the fundamental mechanisms and therapeutic significance of chitosan-based microstructures (microspheres and microcapsules) for transporting natural compounds. Key formulation parameters—such as molecular weight, degree of cross-linking, and microparticle size—are evaluated for their impact on drug loading and release behavior. Evidence shows that chitosan microencapsulation enhances therapeutic outcomes in various applications, including cancer therapy, gastrointestinal disorders, orthopedic regeneration, and tissue repair. The review also discusses advanced strategies, including surface functionalization and hybrid composite systems, developed to further improve chitosan’s performance. Despite substantial progress, clinical translation remains hindered by variability in material quality and regulatory constraints. Addressing these challenges through standardized characterization methods and scalable manufacturing approaches is essential for advancing chitosan microcarriers into clinically viable platforms for natural product therapeutics.
Recent advances in lipid nanoparticles for cancer vaccine delivery: Challenges and future perspectives Nurhasni Hasan, Maryam Aftab, Sania Ikram, Apon Zaenal Mustofa, Sriwidodo Sriwidodo, Huda Shalahudin Darusman, Muhammad Nur Amir, Theofilus A. Tockary, Satoshi Uchida International Journal of Pharmaceutics X, 2026 Cancer remains a major global health burden, with 19.3 million new cases and 10.3 million deaths reported in 2020. Conventional modalities such as surgery, radiotherapy, and chemotherapy often fail to prevent metastasis or recurrence. Cancer vaccination, which mobilizes durable, tumor-specific immunity, has gained traction, and LNPs have become pivotal to this approach. Originally optimized for siRNA, LNPs' core-shell architecture protects nucleic acids, enhances cellular uptake, and enables efficient cytosolic delivery. Their clinical validation in infectious-disease messenger RNA (mRNA) vaccines has catalyzed rapid progress toward oncology applications. Preclinical and early-phase trials have indicated that mRNA-LNPs encoding tumor-associated antigens or patient-specific neoantigens can expand cytotoxic T cells and elicit preliminary antitumor activity. Key barriers remain. Manufacturing cost and batch consistency challenge scale-up. Physicochemical instability necessitates cold-chain logistics and complicates global deployment. Reactogenicity and anti-PEG antibodies increase safety and dosing concerns. Within tumors, immunosuppressive microenvironments, heterogeneous antigen expression, and suboptimal lymphoid targeting limit the efficacy of vaccines. This review describes the advances in LNP design (ionizable and biodegradable lipids, PEG alternatives, ligand-mediated targeting), formulation strategies (thermostable and lyophilized systems), and delivery routes (intranodal and intratumoral) to overcome these bottlenecks. It also highlights synergistic combinations with checkpoint blockade, radiotherapy, and innate agonists, and examines emerging pipelines leveraging AI-guided neoantigen discovery and quality control. By integrating material engineering, immunology, and translational evidence, we identified failure points and proposed a roadmap for next-generation LNP-based cancer vaccines. The goal is to accelerate progress from bench to clinic, while improving manufacturability, access, and durable patient benefits.
In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches Ahmad Fariz Maulana, Sriwidodo Sriwidodo, Iman Permana Maksum, Yaya Rukayadi Admet and Dmpk, 2026 Background and purpose: Diabetes mellitus type 2 is a global health issue marked by hyperglycemia and metabolic dysfunction. Despite progress, discovering safe and effective antidiabetic agents remains crucial. This review highlights integrated In Silico, In Vitro, and in vivo methods for identifying novel antidiabetic compounds from natural and synthetic origins. Experimental approach: Computational tools including molecular docking, molecular dynamics, and ADMET prediction identified inhibitors targeting DPP-IV, α-glucosidase, and PPAR. Promising compounds underwent in vitro enzymatic and cellular assays, followed by in vivo efficacy tests in diabetic animal models assessing glucose levels, biochemical markers, and tissue histopathology. Key results: Integrated computational and experimental approaches effectively pinpointed compounds with strong target binding, enzyme inhibition, and positive cellular effects. In vivo data showed significant glucose reduction, enhanced insulin response, and pancreatic protection. ADMET analysis further supported their drug-likeness and safety profiles. Conclusion: Combining computational screening with biological validations forms a cost-effective pipeline for antidiabetic drug discovery. Multi-disciplinary integration increases lead identification success, guiding future refinement of in silico models and expanded in vivo studies to accelerate novel diabetes therapeutic development.
Development of Amorphous Solid Dispersion to Improve the Dissolution and Antiproliferative Activity of Brazilin Deby Tristiyanti, Sriwidodo Sriwidodo, Syarif Hamdani, Isti Daruwati, Arif Budiman Drug Design Development and Therapy, 2026 Introduction: Brazilin (BRZ), a major bioactive constituent of Caesalpinia sappan , exhibits promising anticancer activity but suffers from extremely poor aqueous solubility, limiting its oral bioavailability and therapeutic efficacy. Drug solubility is a critical determinant of absorption and therapeutic efficacy, so strategies to enhance the solubility of BRZ are essential. Amorphous solid dispersions (ASDs) have been widely employed to enhance the solubility and dissolution behavior of poorly soluble compounds. This study aimed to develop and characterize ASDs of BRZ using polyvinylpyrrolidone (PVP) as a polymer carrier, to investigate molecular interactions through in silico docking, and to evaluate their physicochemical properties, dissolution behavior, physical stability, and antiproliferative activity. Methods: ASDs of BRZ with PVP were prepared using the solvent evaporation method with drug-to-polymer weight ratios of 1:1, 1:3, and 1:5. The formulations were characterized using powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), and Fourier-transform infrared (FT-IR) spectroscopy. Solubility, in vitro dissolution, and antiproliferative activity against DU145 prostate cancer cells were evaluated. Physical stability was evaluated over 30 days under dry (25 °C/0% RH) and humid (25 °C/90% RH) storage conditions using PXRD to detect any possible recrystallization. Results: PXRD and DSC analyses confirmed the complete amorphization of BRZ within the ASD matrix, as evidenced by the disappearance of crystalline diffraction peaks and characteristic melting endotherms. FT-IR spectroscopy, supported by in silico studies, revealed hydrogen bond formation between the hydroxyl group of BRZ and the carbonyl group of PVP. The BRZ:PVP (1:5) formulation achieved a 5.7-fold increase in solubility compared to crystalline BRZ. Dissolution testing showed a characteristic spring-and-parachute profile, with ASDs maintaining supersaturation for a prolonged period. Moreover, enhanced antiproliferative activity against DU145 cells was observed for BRZ ASDs, with the lowest IC 5 0 value of 14.02 μg/mL at a 1:5 ratio, compared to 20.12 μg/mL for crystalline BRZ. Stability testing showed that all ASDs maintained their amorphous form under dry storage conditions for 30 days, whereas samples stored at 90% relative humidity exhibited recrystallization. Conclusion: BRZ ASDs using PVP effectively improved solubility, dissolution profile, and antiproliferative activity. The formulations demonstrated good stability under dry storage conditions but were sensitive to high humidity. These findings suggest that ASDs represent a promising strategy for enhancing the therapeutic potential of poorly soluble natural anticancer compounds. Keywords: brazilin, amorphous solid dispersion, polyvinylpyrrolidone, dissolution, antiproliferative effects
Natural Bioactive-Based Advanced Wound Dressings for Diabetic Wound Healing: A Systematic Review of Emerging Biomaterial Platforms Andhi Fahrurroji, Cecep Suhandi, Anis Chaerunisaa, Liza Pratiwi, Sriwidodo Sriwidodo International Journal of Nanomedicine, 2026 Background: Diabetic ulcers are complex wounds that are difficult to treat due to persistent inflammation, excessive oxidative stress, impaired angiogenesis, and microbial infections that disrupt normal healing. Advanced wound dressings such as hydrogels, nanofibre matrices, hydrocolloids, and 3D bioprinted constructs are increasingly developed to incorporate natural bioactive compounds with multifunctional therapeutic properties. However, systematic understanding of their mechanisms and translational relevance remains limited. Objective: This study aims to systematically review natural-based hydrogel, hydrocolloid, and hydrofiber formulations in diabetic wound healing. Methods: A Systematic Literature Review following PRISMA guidelines was conducted using ScienceDirect, SpringerLink, PubMed, and Scopus (2020-2025). Risk of bias was assessed using SYRCLE's tool. Results: From 5256 initial records, 4412 articles were screened, and 14 studies were included after applying eligibility criteria. These studies examined advanced dressings such as hydrogels, hydrocolloids, nanofibers, 3D bioprinted constructs, and hybrid nanocomposites incorporating natural bioactive compounds. The formulations demonstrated antimicrobial, anti-inflammatory, antioxidant, pro-angiogenic, and re-epithelialization effects. Common compounds included curcumin, berberine, propolis, bee venom, and plant extracts combined with polymers such as chitosan, alginate, hyaluronic acid, collagen, and GelMA. Advanced fabrication improved drug delivery, physicochemical properties, and healing outcomes. At the molecular level, these systems modulated pathways such as NF-κB, PI3K/Akt, MAPK, VEGF, and TGF-β/Smad, contributing to reduced inflammation, oxidative stress suppression, enhanced angiogenesis, and extracellular matrix remodeling. Risk of bias assessment indicated unclear risks in randomization and blinding, although internal validity was generally acceptable Translational readiness remained limited (TRL 2-6), with hydrogels and nanosystems showing the highest potential, while 3D bioprinting faces scalability and regulatory challenges. Conclusion: Natural-based advanced dressings offer a promising strategy for diabetic wound management. Successful clinical translation requires alignment with scalability, stability, cost-effectiveness, and regulatory compliance. Future research should prioritize standardized preclinical models, controlled release systems, and scalable, regulation-compliant biomaterial designs to accelerate clinical application.
Design Evolution of Curcumin-Loaded Nanostructured Lipid Carriers: Formulation Strategies, Functional Modifications, and Mechanistic–Translational Perspectives Ikra Nurohman, Cecep Suhandi, Anis Chaerunisaa, Gofarana Wilar, Garnadi Jafar, Sriwidodo Sriwidodo International Journal of Nanomedicine, 2026 Curcumin possesses broad therapeutic potential but remains severely limited by poor solubility, instability, and low systemic bioavailability. Nanostructured lipid carriers (NLCs) have emerged as an advanced lipid-based delivery platform capable of overcoming these constraints through optimized lipid organization, high drug-loading capacity, and tunable surface functionality. This review provides a comprehensive examination of the design evolution of curcumin-loaded NLCs (Cur-NLCs), encompassing core components, formulation strategies, preparation techniques, and quality determinants that govern physicochemical and biological performance. Evidence-based classification of formulation approaches is presented, highlighting single-drug, co-loaded, and surface-modified or functionally engineered NLC systems and their respective therapeutic advantages. Mechanistic insights are discussed to elucidate how NLCs enhance curcumin's stability, absorption, intracellular trafficking, and controlled release. Current challenges, including formulation heterogeneity, scalability, long-term stability, and translational readiness, are critically evaluated, alongside emerging clinical observations from engineered NLCs that further underscore their translational relevance. From a translational standpoint, the review identifies NLC designs based on pharmaceutically accepted lipids, scalable preparation methods, and minimal surface complexity as the most feasible candidates for near-term clinical development, while more elaborate multifunctional or ligand-modified systems are discussed as promising but longer-term strategies. However, the progress outlined in this review highlights NLCs as a highly adaptable platform capable of unlocking curcumin's full pharmacological potential and accelerating its pathway toward therapeutic applicability.
Sacha Inchi Oil–Based Nanostructured Lipid Carriers for Curcumin Delivery: Development and Physicochemical Characterization Ikra Nurohman, Anis Chaerunisaa, Gofarana Wilar, Garnadi Jafar, Cecep Suhandi, Sriwidodo Sriwidodo Nanotechnology Science and Applications, 2026 Background and Objective: Curcumin exhibits potent antioxidant activity beneficial for the prevention of various degenerative diseases; however, its highly lipophilic nature and susceptibility to degradation limit its solubility and physicochemical stability. To address these limitations, curcumin was formulated into nanostructured lipid carriers (NLCs), a lipid-based colloidal delivery system composed of solid and liquid lipids stabilized by surfactants. In this study, sacha inchi oil, a natural oil rich in omega-3 and other unsaturated fatty acids, was investigated as a novel liquid lipid component to improve lipid matrix structure and drug accommodation. Methods: Curcumin-loaded NLCs were prepared using the hot homogenization method followed by probe sonication. Curcumin served as the active compound, while solid lipids (oleum cacao, glyceryl behenate (Compritol ® 888 ATO), or glyceryl palmitostearate (Precirol ® ATO 5)), sacha inchi oil as the liquid lipid, and surfactants (Tween 80, Poloxamer, or a Tween 80–Span 80 combination) were used. The resulting NLCs were characterized in terms of particle size, polydispersity index (PDI), zeta potential (ZP), entrapment efficiency (EE), physicochemical properties (FTIR, DSC, XRD), morphology, and in vitro release behavior. Results: Physicochemical analyses confirmed successful incorporation of curcumin into the lipid matrix without undesirable interactions. Among the tested formulations, CaTS2 (oleum cacao 4.5%, sacha inchi oil 1%, Tween 80 12.5%, Span 80 1%, and curcumin 0.1%) demonstrated the most favorable characteristics, with a particle size of 95.50 ± 0.87 nm, PDI of 0.119 ± 0.157, and ZP of − 22.30 ± 0.98 mV. Entrapment efficiency reached 97.24% and morphological analysis showed predominantly spherical particles. In vitro release exhibited a biphasic pattern, consisting of an initial burst followed by sustained release up to 480 min. Kinetic modeling revealed that CaTS2 followed the Korsmeyer–Peppas model ( R2 = 0.793; n = 0.301), consistent with Fickian diffusion, whereas pure curcumin followed the Higuchi model ( R2 = 0.819). The similarity factor (f 2 = 29.04) indicated a distinctly different release profile between the two systems. Conclusion: Sacha inchi oil–based nanostructured lipid carriers were successfully developed and demonstrated favorable physicochemical characteristics, supporting their potential as a stable delivery system for curcumin. Keywords: curcumin, nanostructured lipid carriers, sacha inchi oil, drug delivery, lipid-based nanoparticle
Study of various forms of propolis nanoparticles and their antibacterial effectiveness Ammar Fadhil, Sriwidodo, Khaled M. Elamin, Ahmed Fouad Abdelwahab Mohammed, Safwat A Mahmoud, Nasrul Wathoni Opennano, 2026 Most bacteria are beneficial to human health, but some have pathogenic properties. Pathogenic bacteria cause diseases in the host by directly damaging tissues or cells during replication via toxin production. Propolis nanoparticles is a method that has the potential to be an effective antibacterial. Advantages of using nanotechnology include boosting the drug delivery system and absorption of active herbal medicine substances, which have poor bioavailability owing to their high molecular weight, improved solubility, rapid penetration with low cytotoxicity, reduced drug dosage, and fewer side effects. This study reviews the literature on the effectiveness of propolis in various forms of nanoparticle technology as an antibacterial agent, which may help researchers to develop nanoparticle technology in the pharmaceutical industry. We conducted this research using search engines, including Scopus, PubMed, and ScienceDirect, with the keywords " Nanoparticles,”" Propolis,”and "Antibacterial,” without limiting the year of publication. We conducted a search between April and June 2025. They related the reviewed articles to knowledge of nanoparticle use. Propolis is a natural resinous substance produced by honeybees in various forms. These parameters were used to extract 1699 articles, which were reviewed and examined. The study identified eight types of propolis nanoparticles with antibacterial properties: nanoemulsions, nanostructured lipid carriers (NLC), nanosheets, metal nanoparticles, chitosan nanoparticles, nanoencapsulation, solid lipid nanoparticles (SLN), and polymer nanoparticles. The effectiveness of antibacterial propolis nanoparticles varies agents. The metallic form of propolis nanoparticles is the most effective nanoparticles. Metallic propolis nanoparticles can inhibit 19 types of bacteria and can be applied in eight different forms.
Antistunting potential of deepsea water concentrate as multivitamin granules: stability and in vivo activity study Barmi Hartesi, Bambang Retnoaji, Sriwidodo Sriwidodo, Yoga Windhu Wardhana, Muhaimin Muhaimin, Mayang Kusuma Dewi, Sjaikhurrizal El Muttaqien, Anis Yohana Chaerunisaa Scientific Reports, 2025 Stunting in children is caused by severely inadequate nutrients; therefore, balanced nutritious foods such as multivitamins is the most promising alternative interventions. Concentrated deep seawater is rich in minerals, thus provide potent multivitamin sources. The hygroscopic nature of minerals makes them prone to moisture. Consequently, the fabrication of a non-hygroscopic dosage form and the study on its potential for stunting conditions are highly needed. The concentrate was encapsulated into granules by using different fillers with Florite as desiccant. Physicochemical evaluations were conducted using Differential Scanning Calorimetry (DSC), X-ray Diffraction (XRD), and Scanning Electron Microscopy (SEM). An in vivo anti-stunting study was performed using zebrafish as an animal model. The results indicated that encapsulation using Avicel PH 102 as filler, either with or without addition of Florite 10%, provided good stability after 5 months of storage. Antistunting activity test showed that, after induction by rotenone, treatments with deep seawater either in form of concentrate water or granule improved the stunted condition of the zebra fish embryos shown as the improvement in the hatching rate, brain length, and body length. Deep seawater concentrate was successfully formulated into granules which provided moisture protection of its highly hygroscopic nature as well as antistunting activity.
Pro-environmental behaviour of healthcare professionals: A study applying theory of planned behaviour International Journal of Business and Globalisation, 2021
Drug delivery system by hydrogel soft contact lens materials: A review Journal of Pharmaceutical Sciences and Research, 2018
Synthesis of sodium carboxymethyl cellulose (Na-CMC) from water hyacinth with mixed solvent using succinic acid and epichlorohydrin as crosslinker Research Journal of Chemistry and Environment, 2018
Extracellular secretion of recombinant human epidermal growth factor by using trimethylamine N-Oxide reductase a (TORA) signal peptide in escherichia coli BL21 (DE3) Journal of Pharmaceutical Sciences and Research, 2017
The sterility of reusable instruments at Central Surgery installation’s room storage of one of the hospital in Bandung Journal of Pharmaceutical Sciences and Research, 2017
Extracellular secretion recombinant of human epidermal growth factor (hEGF) using pectate lyase B (PelB) signal peptide in escherichia coli BL21(DE3) International Journal of Research in Pharmaceutical Sciences, 2017
Starch as pharmaceutical excipient International Journal of Pharmaceutical Sciences Review and Research, 2016
Epichlorohydrin as crosslinking agent for synthesis of carboxymethyl cellulose sodium (Na-CMC) as pharmaceutical excipient from water hyacinth (Eichorrnia Crassipes L.) International Journal of Chemical Sciences, 2015
Natural Bioactive-Based Advanced Wound Dressings for Diabetic Wound Healing: A Systematic Review of Emerging Biomaterial Platforms A Fahrurroji, C Suhandi, AY Chaerunisaa, L Pratiwi, S Sriwidodo International Journal of Nanomedicine, 588990 , 2026 2026
Sacha inchi oil–based nanostructured lipid carriers for curcumin delivery: development and physicochemical characterization I Nurohman, AY Chaerunisaa, G Wilar, G Jafar, C Suhandi, S Sriwidodo Nanotechnology, Science and Applications, 589429 , 2026 2026 Citations: 1
Development of Amorphous Solid Dispersion to Improve the Dissolution and Antiproliferative Activity of Brazilin D Tristiyanti, S Sriwidodo, S Hamdani, I Daruwati, A Budiman Drug Design, Development and Therapy, 579426 , 2026 2026
Design Evolution of Curcumin-Loaded Nanostructured Lipid Carriers: Formulation Strategies, Functional Modifications, and Mechanistic–Translational Perspectives I Nurohman, C Suhandi, AY Chaerunisaa, G Wilar, G Jafar, S Sriwidodo International Journal of Nanomedicine, 586727 , 2026 2026 Citations: 1
Chitosan-Based Microparticulate Systems to Enhance the Bioavailability of Natural Products: Mechanistic Insights and Pharmaceutical Applications P Hasimun, C Suhandi, E Susilawati, D Gozali, R Santoso, T Rusdiana, ... Carbohydrate Polymer Technologies and Applications, 101147 , 2026 2026
In silico based exploration of natural and synthetic antidiabetic compounds: A comprehensive review of computational approaches AF Maulana, S Sriwidodo, IP Maksum, Y Rukayadi ADMET and DMPK 14 , 2026 2026
Screening of Hydrolysis Conditions for Green Pea Protein with Bromelain: A Time-Efficient Approach for CKD-Oriented Nutritional Therapy M Hidayat, K Hasan, M Yusuf, A Hardianto, MT Novianti, S Sriwidodo, ... 2026
Recent advances in lipid nanoparticles for cancer vaccine delivery: Challenges and future perspectives N Hasan, M Aftab, S Ikram, AZ Mustofa, S Sriwidodo, HS Darusman, ... International Journal of Pharmaceutics: X, 100484 , 2026 2026 Citations: 6
Activities Analysis of Encapsulated Mitragyna speciosa Extracts in High-Fat Diet-Induced Rats Model: In vivo and In silico Studies: Nanoparticles of M. speciosa to High-fat … KR Abidin, MRAA Syamsunarno, AM Rosdianto, KK Dharma, R Lesmana, ... Indonesian Journal of Herbal and Biomedical Research 1 (1), 17-39 , 2025 2025
Bee venom in pharmacology: mechanistic insights from pro-inflammatory trigger to anti-inflammatory therapeutic agent S Sriwidodo, C Suhandi, G Wilar, N Wathoni Biomedicine & Pharmacotherapy 192, 118636 , 2025 2025 Citations: 7
Plasma Fractionation: Conditions and Challenges I Rambia, A Insyirah, NSE Claudiana, ZT Al Fath, NE Permadi, ... Indonesian Journal of Pharmaceutical Science and Technology 12 (3), 367-377 , 2025 2025
Antistunting potential of deepsea water concentrate as multivitamin granules: stability and in vivo activity study B Hartesi, B Retnoaji, S Sriwidodo, YW Wardhana, M Muhaimin, MK Dewi, ... Scientific Reports 15 (1), 37905 , 2025 2025
Downregulation of Cyclin-D, Wnt3a, and C-Myc in prostate cancer by dose-dependent combination of concentrated marine minerals and curcumin S Alaydrus, S Sriwidodo, A Diantini, R Amalia, W Wahyuni, A Wulandari Journal of Applied Pharmaceutical Science 15 (11), 058-066 , 2025 2025
Risk Management in the Pharmaceutical Industry Supply Chain at the Pharmaceutical Wholesaler Level S Evi, S Sriwidodo, R Masrahman Indonesian Journal of Pharmaceutics 7 (1), 31-45 , 2025 2025
Analisis Aktivitas Antioksidan Nanoemulsi Berbaris Tanaman dalam Aplikasi Farmasi dan Kosmetik: Kajian Literatur N Aisyah, S Sriwidodo, P Husni, S Sinala Media Kesehatan Politeknik Kesehatan Makassar 20 (1), 139-152 , 2025 2025 Citations: 4
Penggunaan Maltodekstrin pada Enkapsulasi Ekstrak Bahan Alam dan Stabilitasnya Terhadap Ph dan Suhu H Rismawan, A Eri, S Sriwidodo MAHESA: Malahayati Health Student Journal 5 (6), 2557-2571 , 2025 2025 Citations: 2
Standardisation of Fermented Uncaria nervosa Bark Extract as an Anti-Acne Gel Preparation. M Almeida, AC Narsa, SAF Kusuma, S Sriwidodo Tropical Journal of Natural Product Research 9 (5) , 2025 2025
Systematic Review: Metode dan Aplikasi Mikroenkapsulasi pada Ekstrak Bahan Alam F Muharam, S Sriwidodo, E Amalia MAHESA: Malahayati Health Student Journal 5 (5), 1882-1895 , 2025 2025 Citations: 3
Antioxidant and photoprotective activity of bromelain cream: An in vitro and in vivo study Z Marissa, SR Mita, CK Kusumawulan, S Sriwidodo Cosmetics 12 (2), 41 , 2025 2025 Citations: 11
Transfersomes for Optimal Penetration of α-Mangostin (Garcinia mangostana L.) in Cosmetic Products using Vortexing-Sonication YD Putri, D Tristiyanti, WP Legowo, NK Sari, S Sriwidodo Indonesian Journal of Pharmaceutics 5 (2), 432-440 , 2025 2025
MOST CITED SCHOLAR PUBLICATIONS
Review sistematik: proses penyembuhan dan perawatan luka H Purnama, RS Sriwidodo, S Ratnawulan Farmaka 15 (2), 251-256 , 2017 2017 Citations: 139
Microcrystalline cellulose as pharmaceutical excipient AY Chaerunisaa, S Sriwidodo, M Abdassah Pharmaceutical formulation design-recent practices, 1-21 , 2019 2019 Citations: 137
Film-forming sprays for topical drug delivery AK Umar, M Butarbutar, S Sriwidodo, N Wathoni Drug Design, Development and Therapy, 2909-2925 , 2020 2020 Citations: 125
Perkembangan teknologi terkini dalam mempercepat produksi vaksin COVID-19 IP Sari, S Sriwidodo Majalah Farmasetika 5 (5), 204-217 , 2020 2020 Citations: 113
Starch as pharmaceutical excipient B Hartesi, AM Sriwidodo, AY Chaerunisaa Int J Pharm Sci Rev Res 41 (2), 59-64 , 2016 2016 Citations: 75
A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant I Purwaningsih, IP Maksum, D Sumiarsa, S Sriwidodo Molecules 28 (3), 1294 , 2023 2023 Citations: 68
Film-forming spray of water-soluble chitosan containing liposome-coated human epidermal growth factor for wound healing AK Umar, S Sriwidodo, IP Maksum, N Wathoni Molecules 26 (17), 5326 , 2021 2021 Citations: 59
Effect of drug–polymer interaction in amorphous solid dispersion on the physical stability and dissolution of drugs: The case of alpha-mangostin A Budiman, NV Nurani, E Laelasari, M Muchtaridi, S Sriwidodo, DL Aulifa Polymers 15 (14), 3034 , 2023 2023 Citations: 43
Nanoparticle-based antioxidants in stress signaling and programmed cell death in breast cancer treatment Y Herdiana, S Sriwidodo, FF Sofian, G Wilar, A Diantini Molecules 28 (14), 5305 , 2023 2023 Citations: 43
Inhibition of crystal nucleation and growth in aqueous drug solutions: impact of different polymers on the supersaturation profiles of amorphous drugs—the case of alpha-mangostin A Budiman, ZG Citraloka, M Muchtaridi, S Sriwidodo, DL Aulifa, A Rusdin Pharmaceutics 14 (11), 2386 , 2022 2022 Citations: 35
Preparation of mangosteen peel extract microcapsules by fluidized bed spray-drying for tableting: improving the solubility and antioxidant stability S Sriwidodo, R Pratama, AK Umar, AY Chaerunisa, AT Ambarwati, ... Antioxidants 11 (7), 1331 , 2022 2022 Citations: 33
Proses penyembuhan dan perawatan luka: review sistematik H Purnama, S Sriwidodo, SR Mita Farmaka 15 (2), 251-258 , 2017 2017 Citations: 32
Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 Mpro inhibitor AK Umar, JH Zothantluanga, JA Luckanagul, P Limpikirati, S Sriwidodo PeerJ 11, e14915 , 2023 2023 Citations: 27
Microcrystalline cellulose as pharmaceutical excipient A Yohana Chaerunisaa, S Sriwidodo, M Abdassah Pharmaceutical formulation design-recent practices. IntechOpen: London , 2020 2020 Citations: 26
The impact of water-soluble chitosan on the inhibition of crystal nucleation of alpha-mangostin from Supersaturated Solutions A Budiman, N Nurfadilah, M Muchtaridi, S Sriwidodo, DL Aulifa, A Rusdin Polymers 14 (20), 4370 , 2022 2022 Citations: 24
Extracellular secretion of recombinant human epidermal growth factor by using trimethylamine N-Oxide reductase a (TORA) signal peptide in Escherichia coli BL21 (DE3) IP Maksum, E Utama, ST Sriwidodo, T Subroto J Pharm Sci Res 9 (6), 1007-16 , 2017 2017 Citations: 24
Extracellular secretion recombinant of human epidermal growth factor (hEGF) using pectate lyase B (PelB) signal peptide in Escherichia coli BL21 (DE3) S Sriwidodo, IP Maksum, N Riswanto, T Rostinawati, T Subroto Int J Res Pharm Sci 8 (1), 1-8 , 2017 2017 Citations: 24
Overview of refolding methods on misfolded recombinant proteins from Escherichia coli inclusion bodies A Nabiel, Y Yosua, S Sriwidodo, IP Maksum J. App Biol. Biotech 11, 47-52 , 2023 2023 Citations: 21
Optimization extracellular secretion of recombinant human epidermal growth factor (hEGF) in Escherichia coli BL21 (DE3) pD881-OmpA-hEGF by using response surface method (RSM) A Indriyani, NI Anggraeni, S Sriwidodo, IP Maksum Int J Res Pharm Sci 10 (3), 1824-1831 , 2019 2019 Citations: 21
Physicochemical characteristics, fatty acid profile, and in vitro antioxidant activity evaluation of sacha inchi seed oil from Indonesia I Maya, DO Winardi, E Amalia, SR Mita, CK Kusumawulan, NA Putriana, ... Cosmetics 10 (6), 171 , 2023 2023 Citations: 20